CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
When expertise became just another opinion : Rebuilding trust through a transparent infrastructure for verified scientific knowledge. [PDF]
Marzec M.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
From Photoluminescence Optimization to Green LED Fabrication: The Role of Molar Precursor Ratio in Carbon Dots. [PDF]
Trapani D +6 more
europepmc +1 more source
Fragile research systems, brain drain, and predatory publishing in under-resourced countries. [PDF]
Jonjić S +7 more
europepmc +1 more source
The Reform That Was Never Completed: Why Greece Must Redesign Its Health Financing Architecture. [PDF]
Flokou A, Aletras V, Niakas DA.
europepmc +1 more source
Scaling biodiversity conservation through institutional reform. [PDF]
Zhang L +10 more
europepmc +1 more source
Spectrofluorimetric Method for Sensitive Histamine Detection Using Europium Complexation. [PDF]
Kamel KB +5 more
europepmc +1 more source
Wrestling the Two-Headed Hydra: On the Consequences of the Bifurcated Concept of "Undertaking" in EU Competition Law. [PDF]
Grzejdziak Ł.
europepmc +1 more source

